Precigen, Inc
Clinical trials sponsored by Precigen, Inc, explained in plain language.
-
New combo aims to outsmart Drug-Resistant cervical cancer
Disease control Recruiting nowThis phase 2 study is testing whether adding an experimental therapy called PRGN-2009 to the immunotherapy drug pembrolizumab can help shrink tumors in people with recurrent or metastatic cervical cancer that has stopped responding to pembrolizumab alone. About 24 adults with HPV…
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests a gene therapy called Zopapogene imadenovec (Zopa) in 30 adults with recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous throat tumors that often require repeated surgeries. One group will check how the virus used in the therapy leaves t…
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC